17249 Search Results


90
Bio-Techne corporation nb120-17249
Nb120 17249, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nb120-17249/product/Bio-Techne corporation
Average 90 stars, based on 1 article reviews
nb120-17249 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Addgene inc pcm1 36
Pcm1 36, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcm1 36/product/Addgene inc
Average 90 stars, based on 1 article reviews
pcm1 36 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

93
Proteintech human znf611
Correlation analysis of differentially expressed PRLs used for model development. (A, B) Analyses of the differential expression of AC016394.2 and AC022150.4 in tumour and adjacent tissues, and associated survival trends. (C) Correlation between the genes regulated by AC016394.2 ( SEC24C , SMARCAD1 , and AP3M1 ) and AC016394.2 , as well as the correlation between the genes regulated by AC022150.4 ( <t>ZNF611</t> and USP34 ) and AC022150.4 . (D) Differences in the positive and negative regulatory relationships between the risk of BC associated with lncRNAs and various genes. ** P < 0. 01, *** P < 0. 001.
Human Znf611, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human znf611/product/Proteintech
Average 93 stars, based on 1 article reviews
human znf611 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

90
Purdue University Cytometry paper 17249
Correlation analysis of differentially expressed PRLs used for model development. (A, B) Analyses of the differential expression of AC016394.2 and AC022150.4 in tumour and adjacent tissues, and associated survival trends. (C) Correlation between the genes regulated by AC016394.2 ( SEC24C , SMARCAD1 , and AP3M1 ) and AC016394.2 , as well as the correlation between the genes regulated by AC022150.4 ( <t>ZNF611</t> and USP34 ) and AC022150.4 . (D) Differences in the positive and negative regulatory relationships between the risk of BC associated with lncRNAs and various genes. ** P < 0. 01, *** P < 0. 001.
Paper 17249, supplied by Purdue University Cytometry, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/paper 17249/product/Purdue University Cytometry
Average 90 stars, based on 1 article reviews
paper 17249 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Correlation analysis of differentially expressed PRLs used for model development. (A, B) Analyses of the differential expression of AC016394.2 and AC022150.4 in tumour and adjacent tissues, and associated survival trends. (C) Correlation between the genes regulated by AC016394.2 ( SEC24C , SMARCAD1 , and AP3M1 ) and AC016394.2 , as well as the correlation between the genes regulated by AC022150.4 ( ZNF611 and USP34 ) and AC022150.4 . (D) Differences in the positive and negative regulatory relationships between the risk of BC associated with lncRNAs and various genes. ** P < 0. 01, *** P < 0. 001.

Journal: Frontiers in Immunology

Article Title: Construction of a prognostic model based on palmitoylation-related lncRNAs for assessing drug benefits in breast cancer

doi: 10.3389/fimmu.2025.1656593

Figure Lengend Snippet: Correlation analysis of differentially expressed PRLs used for model development. (A, B) Analyses of the differential expression of AC016394.2 and AC022150.4 in tumour and adjacent tissues, and associated survival trends. (C) Correlation between the genes regulated by AC016394.2 ( SEC24C , SMARCAD1 , and AP3M1 ) and AC016394.2 , as well as the correlation between the genes regulated by AC022150.4 ( ZNF611 and USP34 ) and AC022150.4 . (D) Differences in the positive and negative regulatory relationships between the risk of BC associated with lncRNAs and various genes. ** P < 0. 01, *** P < 0. 001.

Article Snippet: The antibodies used in this study included: anti-SEC24C (Novus, NBP2-94294-0.02ml) for human SEC24C; anti-ZNF611 (CUSABIO, CSB-PA026891GA01HU) for human ZNF611; anti-Ki67 (Proteintech, 28074-1-AP) for mouse Ki67; anti-β-actin (GenScript, A00702); anti-GAPDH (Proteintech, 60004-1-Ig); HRP-linked anti-Mouse IgG (CST, 7076); and HRP-linked anti-Rabbit IgG (CST, 7074).

Techniques: Quantitative Proteomics

Prediction of the potential immune roles of SEC24C and ZNF611 at the single-cell level. (A, B) Clustering and annotation of the BRCA_EMTAAB8107 BC dataset. (C, D) Malignant and CD8+ T cells were the most abundant cell types in the dataset. (E, F) SEC24C and ZNF611 were predominantly localized in mast cells.

Journal: Frontiers in Immunology

Article Title: Construction of a prognostic model based on palmitoylation-related lncRNAs for assessing drug benefits in breast cancer

doi: 10.3389/fimmu.2025.1656593

Figure Lengend Snippet: Prediction of the potential immune roles of SEC24C and ZNF611 at the single-cell level. (A, B) Clustering and annotation of the BRCA_EMTAAB8107 BC dataset. (C, D) Malignant and CD8+ T cells were the most abundant cell types in the dataset. (E, F) SEC24C and ZNF611 were predominantly localized in mast cells.

Article Snippet: The antibodies used in this study included: anti-SEC24C (Novus, NBP2-94294-0.02ml) for human SEC24C; anti-ZNF611 (CUSABIO, CSB-PA026891GA01HU) for human ZNF611; anti-Ki67 (Proteintech, 28074-1-AP) for mouse Ki67; anti-β-actin (GenScript, A00702); anti-GAPDH (Proteintech, 60004-1-Ig); HRP-linked anti-Mouse IgG (CST, 7076); and HRP-linked anti-Rabbit IgG (CST, 7074).

Techniques:

The role of LNCRNA in palmitoylation modification of co-expressed proteins. (A) The expression levels of both LncRNA and target gene Mrna. (B) The protein expression status of their interacting proteins after overexpression of two LncRNAs respectively. (C) SEC24C and ZNF611 palmitoylation in sh-LncRNA lentivirus–infected HEK293T cells analysed by ABE assay. ns, not significant ( P > 0.05).

Journal: Frontiers in Immunology

Article Title: Construction of a prognostic model based on palmitoylation-related lncRNAs for assessing drug benefits in breast cancer

doi: 10.3389/fimmu.2025.1656593

Figure Lengend Snippet: The role of LNCRNA in palmitoylation modification of co-expressed proteins. (A) The expression levels of both LncRNA and target gene Mrna. (B) The protein expression status of their interacting proteins after overexpression of two LncRNAs respectively. (C) SEC24C and ZNF611 palmitoylation in sh-LncRNA lentivirus–infected HEK293T cells analysed by ABE assay. ns, not significant ( P > 0.05).

Article Snippet: The antibodies used in this study included: anti-SEC24C (Novus, NBP2-94294-0.02ml) for human SEC24C; anti-ZNF611 (CUSABIO, CSB-PA026891GA01HU) for human ZNF611; anti-Ki67 (Proteintech, 28074-1-AP) for mouse Ki67; anti-β-actin (GenScript, A00702); anti-GAPDH (Proteintech, 60004-1-Ig); HRP-linked anti-Mouse IgG (CST, 7076); and HRP-linked anti-Rabbit IgG (CST, 7074).

Techniques: Modification, Expressing, Over Expression, Infection